Skip to main content
Journal of Studies on Alcohol and Drugs logoLink to Journal of Studies on Alcohol and Drugs
. 2011 May;72(3):497–506. doi: 10.15288/jsad.2011.72.497

Motivational Interviewing for Incarcerated Adolescents: Effects of Depressive Symptoms on Reducing Alcohol and Marijuana Use After Release*

L A R Stein 1,†, Rebecca Lebeau 1, Suzanne M Colby 1,†, Nancy P Barnett 1,†, Charles Golembeske 1,†, Peter M Monti 1,†
PMCID: PMC3084364  PMID: 21513687

Abstract

Objective:

Motivational interviewing to reduce alcohol and marijuana use among incarcerated adolescents was evaluated.

Method:

Adolescents (N = 162, 84% male; M = 17.10 years old) were randomly assigned to receive motivational interviewing or relaxation training, with follow-up assessment 3 months after release.

Results:

Compared with those who received relaxation training, adolescents who received motivational interviewing had lower rates of alcohol and marijuana use at follow-up, with some evidence for moderating effects of depression. At low levels of depression, adolescents who received motivational interviewing had lower rates of use. Adolescents who received relaxation training and who had high levels of depressive symptoms early in incarceration showed less use at follow-up than those low in depressive symptoms who received relaxation training.

Conclusions:

This brief motivational interviewing intervention during incarceration reduces alcohol and marijuana use after release. In addition, depressive symptoms early in incarceration should be considered in treating these adolescents, but more work is needed to extend follow-up period and account for the impact of depression on outcomes.


Rates of alcohol and marijuana use are high among youths involved in the juvenile justice system. An investigation of substance use by adolescents involved in the juvenile justice system found that those arrested in the past year were twice as likely to have used alcohol and 3.5 times more likely to have used marijuana compared with adolescents who were not arrested in the last year (National Center on Addiction and Substance Abuse at Columbia University, 2004). Rates of alcohol and marijuana use disorders among detainees are approximately 26.1% and 43.3%, respectively, and adolescent detainees show relatively high rates of depression or dysthymia (29.6%; Teplin et al., 2002). Incarcerated adolescents with negative mood (especially depression) have higher levels of alcohol use, have more consequences from alcohol and marijuana, use to regulate emotions, and use more avoidant coping than their normal-mood counterparts (Turner et al., 2005). Similarly, incarcerated adolescents with a history of drinking problems have significantly more negative affect (including depression), have significantly more cognitive distortions typical of depression, and use less social support as a means of coping (Esposito-Smythers et al., 2008). Among juvenile detainees, prevalence of comorbid affective disorder and substance use disorder is about 21%—73% (Abram et al., 2003). Because depressive symptoms are often related to substance use, such dysphoria may have an impact on treatment outcomes for substance-involved adolescents.

Very little work has been done to evaluate substance use interventions for adolescents involved in the juvenile justice system. Stein et al. (2006a) randomly assigned substance-involved incarcerated adolescents to motivational interviewing (MI; Miller and Rollnick, 2002) or to relaxation training (RT) and found that MI resulted in better treatment engagement 2 months into standard facility care. From these same data, the investigators found that 3 months after release, for those adolescents low in depressive symptoms, persons who received MI had lower rates of risky behaviors (e.g., drinking and driving, being a passenger in a car with someone who had been drinking, having risky sex while using alcohol, and using marijuana) than those who received RT; however, at high levels of depression, effects were equivalent (Stein et al., 2006b; Rosengard et al., 2008).

MI decreases substance-related negative consequences, reduces substance use, and increases treatment engagement, with results particularly strong for those with heavier substance use patterns and/or less motivation to change (Tevyaw and Monti, 2004). Masterman and Kelly (2003) indicate that MI may be particularly well suited to adolescents, given their sensitivity and resistance to adult attempts to control or direct their behavior (Marlatt and Witkiewitz, 2002)—features that may be especially common among delinquent adolescents. MI (Miller and Rollnick, 2002) is ideally suited for correctional settings in that it is brief, can be used as a prelude to other treatments (Bein et al., 1993; Brown and Miller, 1993), and has also been found effective as a stand-alone treatment for substance misuse (see Burke et al., 2002; Colby et al., 1998; Monti et al., 1999). MI is well suited for settings with few resources and for persons who may be high in anger or hostility (Barrett et al., 2001; Karno and Longabaugh, 2004). As many as 40% of juveniles show significant anger when initially detained (Stein et al., 2004).

The impact of depression on substance outcomes has yielded inconsistent findings (Kranzler et al., 1996), with some studies showing it associated with treatment attrition (Curran et al., 2002) and poor substance outcomes for adolescents who received residential treatment (Subramanian et al., 2007) and others showing depression associated with longer duration of abstinence (Charney et al., 1998) and less drinking following inpatient services (Kranzler et al., 1996). Tapert et al. (2003) suggested that depressed mood may make adolescents more amenable to brief substance interventions but that for some adolescents it may be a treatment liability (perhaps by impeding the ability to attend to intervention or mobilize resources). This study evaluates the efficacy of MI versus RT in reducing substance use outcomes for incarcerated adolescents and examines the role of depressive symptoms in moderating outcomes. In this study, main findings at the conclusion of the trial are presented, and the focus is on substance use, as compared with previous work cited above, which focused on other behaviors partway through the trial.

Method

Participants

The sample was recruited at a state juvenile correctional facility in the Northeast, from April 2001 to March 2006. Immediately after adjudication, adolescents were identified as potential candidates for the study if they were between the ages of 14 and 19 years (inclusive) and were sentenced to the facility for 4–12 months (inclusive). Adolescents were included in the study if they met any of the following substance use screening criteria: (1) in the year before incarceration they (1a) used marijuana or drank regularly (at least monthly) or (1b) drank heavily (five or more standard drinks for boys, four or more standard drinks for girls) at least once, (2) they used marijuana or drank in the 4 weeks before the offense for which they were incarcerated, or (3) they used marijuana or drank in the 4 weeks before they were incarcerated. Figure 1 illustrates screening, recruitment, and retention.

Figure 1.

Figure 1

Recruitment and retention

The sample (N = 162) comprised the following racial/ethnic backgrounds: 31.5% Hispanic, 30.3% African American, and 29.6% White; 8.6% self-identified as "other." Most were boys (84%); the average age was 17.10 years (SD = 1.11). In the last year, 59.9% and 88.9% qualified for alcohol and marijuana use disorders, respectively. The number of times adolescents had been previously incarcerated was two (median presented because data were skewed). Most adolescents (89.5%) were enrolled in the standard-care substance use programming offered at the facility (see description below), following our initial treatment at baseline. Differences in basic demographics were explored between the study sample of 162 and the 27 excluded (19 with inadequate substance use data and 8 withdrawn or lost at follow-up; see Figure 1). More persons excluded from the study were White, χ2(1) = 5.19,p < .023. No significant differences were found for gender, racial/ethnic status, depressive symptoms, mother education (a marker for socioeconomic status), sentence length, substance treatment during incarceration, or treatment use after release.

Procedures

Newly sentenced adolescents were screened based on record review (see above). Potential participants were then approached individually to determine eligibility based on substance use screening criteria (see above). All procedures that were used received institutional review board approval. Consent was obtained from legal guardians and assent was obtained from adolescents (adolescents 18 years and older provided consent). Adolescents and guardians provided permission for adolescent participation. Guardians and adolescents were informed that all information was confidential, except for plans to escape, hurt self or others, or reports of child abuse. Following the recruitment process, baseline assessment was conducted, followed by random assignment to treatment, which occurred within about 4 days of baseline assessment. Adolescents then enrolled in facility programming (see below), and about 2 weeks before facility discharge they received booster intervention (MI or RT). Follow-up assessment was made 3 months after release (research staff conducting assessments were blind to treatment assignment). Randomization was accomplished via random numbers table in advance and placed in an envelope by the project coordinator. Following baseline assessment, research staff opened the envelope to learn of intervention assignment. The mean time between baseline assessment and release was 185.10 days (SD = 78.2).

Facility program description.

The study was conducted in the state's sole juvenile correctional facility where adolescents' charges range from simple truancy to murder. About 1,000–1,200 adolescents per year are detained at the facility; 500–600 adolescents are adjudicated to the facility each year, and annual recidivism is about 35%. Adolescents receive group treatment and individualized attention (as indicated) on a variety of topics (sex offending, drug dealing, reducing crime, developing empathy, preventing violence, anger management, etc.).

The facility's standard-care substance misuse treatment is psychoeducational group treatment, which is designed to provide appropriate counseling and rehabilitative services for facility residents. Enrollment usually occurs shortly after adjudication. The program, which meets for 60 minutes twice weekly for 8 weeks (10–12 adolescents per group), is designed to provide information using didactics but also includes interactive elements and videotapes. Topics include the physical, psychological, and social consequences of drug use; HIV risk; defense mechanisms (e.g., denial) and an introduction to Alcoholics Anonymous; overview of coping skills; and treatment resources that are available after release. As needed, groups may focus on conflict resolution, anger management, communication, gang participation, drug dealing, and independent living. Treatment goals include increased knowledge of negative effects of alcohol, tobacco, and other drugs, and accompanying change in attitude regarding use of these substances. These group treatments were available to all adolescents, regardless of their participation in the research study, and were conducted by vendors contracted with the facility.

Assessment.

The assessments consisted of 60- to 90-minute private interviews conducted by a trained bachelor's- or master's-level research assistant. Interview format was used because of concerns about reading levels. Research assistants had about 20 hours of training with 1 hour of group and 1 hour of individual supervision per week. In vivo observations were conducted regularly by a licensed clinical psychologist. All assessment data were reviewed by a licensed clinical psychologist or master's-level project member. Record reviews were completed following completion of the assessments. Assessments occurred at baseline (shortly after adjudication) and at 3 months after release from the facility. Adolescents received a $60 gift certificate at follow-up with $10 bonus if they completed the interview within 1 week of the scheduled date.

Study interventions.

Each adolescent received initial intervention (about 90 minutes at baseline) and booster session (about 60 minutes). Adolescents were randomly assigned to and received intervention (MI or RT) shortly after the baseline assessment to prepare them for the facility's standard-care treatment. For both interventions (MI and RT), research counselors had about 56 hours of manual-ized training with 2 hours of group and 1 hour of individual supervision per week. All study intervention files were reviewed by a licensed clinical psychologist or a master's-level project member. Research counselors were two men and two women; all were White; one had a master's degree; and three had bachelor's degrees. Each research counselor conducted both intervention types. In vivo observations were conducted by a licensed clinical psychologist to maintain intervention fidelity.

Motivational interviewing.

The research counselors' therapeutic style and protocol were based on the principles of MI (Miller and Rollnick, 2002), with focus on empathy, not arguing, developing discrepancy, self-efficacy, and personal choice. Sections of the MI included developing rapport, exploration of motivation (pros and cons), personalized assessment feedback, imagining the future with and without change, and establishing goals. Handouts were provided (e.g., goals chosen). Focus of the intervention was on reduction of alcohol and/or marijuana use and associated risky behaviors and consequences of use (e.g., injuries while drunk or high).

Relaxation training.

RT, administered by research counselors, was designed to control for the effects of attending individual intervention. Participants were instructed in relaxation and use of imagery to produce a sense of calm. Adolescents received feedback and handouts in use of progressive muscle relaxation (closely observing tactile experience as muscles were tensed and relaxed). They were also instructed in imagining a peaceful scene and using the five senses to calmly observe and describe the scene in detail in the present moment as they imagined it ("I see a seagull flying overhead.... As it lands I hear the sand being kicked up and waves crashing… ."). Research counselors maintained rapport and provided generalized advice to stop risky activities involving alcohol and marijuana use. The rationale provided was that these techniques can reduce the stress that leads to use of substances such as alcohol and marijuana; therefore, using these techniques may lead to reduced substance use and the associated risky behaviors and consequences.

Measures

Record review.

The record review was used to enhance truthfulness of self-reported alcohol/marijuana use and illegal activity, in that adolescents were informed at the start of the study that records would be reviewed to verify self-reports. Records contained health and legal information regarding substance use history and charges. Record review was conducted at baseline only.

Background questionnaire.

At baseline, the following sociodemographic information was recorded: age, gender, race/ ethnicity, number of years of school completed, and parent/ guardian educational level.

Structured Clinical Interview for DSM-IV.

This diagnostic interview was developed by First et al. (1996) and has demonstrated reliability and validity. Modules for alcohol and marijuana abuse and dependence were administered at baseline.

Center for Epidemiological Studies-Depression (CES-D) scale.

The CES-D (Radloff, 1991) was administered at baseline, and questions reflect distress over the last week. Coefficient α's for problematic alcohol users have ranged from .85 to .90. The CES-D has been shown to be reliable and valid for use with adolescents (Radloff, 1991). Scores of 16 or greater indicate presence of significant depressive symptomatology (Radloff, 1977); for the study sample, 69.8% had significant depressive symptoms.

Timeline Followback (TLFB).

TLFB is a calendar-assisted approach that measures participants' recollection of their substance use over a specified period of time (Sobell and So-bell, 1992). It has been used to assess alcohol use (Bardone et al., 2000; Sobell and Sobell, 1992), drug use (Midanik et al., 1998), smoking (Lewis-Esquerre et al., 2005), binge eating (Bardone et al., 2000), and sexual behavior (Midanik et al., 1998). TLFB has been shown to have excellent reliability (α's = .79 to .98; Sobell et al., 1979) and strong content, criterion, and construct validity. A 90-day TLFB measuring alcohol and marijuana use was collected at baseline and at follow-up after release; if adolescents were in a controlled environment for 50% of days or greater during an assessment, TLFB variables were not calculated.

Treatment fidelity

Fidelity to treatments was maintained via manualized training, treatments manuals, regular supervision, regular treatment file reviews, and in vivo observations by a licensed psychologist. Tevyaw and Monti (2004) provide details regarding the fidelity measure. Adolescents privately completed evaluation forms assessing whether certain core components of the interventions occur. This included three items assessing the therapeutic relationship (perceived rapport, empathy, self-efficacy). Responses were rated on a scale ranging from 1 (strongly disagree) to 4 (strongly agree). Specific aspects of the protocols were also assessed, as were their perceived utility (0 = topic not introduced to 3 = topic very useful) across 10 items. Average relationship and usefulness ratings were obtained separately. The relationship items assess core elements of MI and should be rated more highly in MI than in RT. On the MI fidelity form, adolescents in MI rated MI-specific items as well as items specific to RT. Therefore, adolescents in MI should rate MI-specific aspects of the protocol more highly on the Likert scale than RT-spe-cific items. On the RT fidelity form, adolescents in RT rated RT-specific items as well as items specific to MI. Therefore, adolescents in RT should rate RT-specific aspects of the protocols more highly than MI-specific items. MI-specific items include a discussion of likes and dislikes regarding substance use, whereas RT-specific items include practicing tensing and relaxing muscle groups. Research counselors independently completed similar forms.

Analyses

Alcohol and marijuana use variables were log transformed so that these data would conform to distributional assumptions (no transformations were needed for number of days used marijuana and percentage of days used marijuana). Analysis of covariance (ANCOVA) was performed to determine the impact of depressed mood on treatment to reduce alcohol and marijuana use. Dependent variables at 3-month post-release assessment were number of drinks per drinking day, average number of drinks per day, percentage of heavy drinking days, percentage of days drank more than five drinks, number of joints smoked per day, and percentage of days used marijuana. Heavy drinking was defined as four or more drinks for girls and five or more drinks for boys. For each ANCOVA, the covariate was the corresponding baseline measure of the dependent variables, and the independent variables were intervention condition and depressive symptoms (CES-D score > 15). Significant main effects are detailed below only in the event of nonsignificant interaction effects. See Tables 2 and 3 for effect sizes for main effects, interactions, and follow-up tests.

Table 2.

Main effects and interaction effects for treatment condition and depressive symptoms on outcomes

Variable Dep.symptoms
MI
RT
Tx effects
Dep. effects
Txby dep. effects
High Low High Low P η2 P η2 P η2
DPDD
 Mb 9.17 6.07 8.62 12.79 1.57(1,94) .016c 0.37(1,94) .004c 4.14(1,94) .042d
 SDb 6.34 3.60 6.42 9.03 p > .200 p > .500 p < .045
 n 34 16 33 16
ADPD
 Mb 0.88 0.55 0.71 2.12 4.34(1, 157) .027c 2.78(1, 157) .017c 3.54(1, 157) .022c
 SDb 2.16 1.36 1.38 3.74 p < .039 p < .098 p < .062
 n 60 26 53 23
PHDD
 Mb 5.15 4.23 5.86 14.54 4.63(1, 157) .029c 2.78(1,157) .017c 0.45 (1, 157) .003c
 SDb 13.09 9.11 11.33 22.27 p < .033 p < .098 p > .500
 n 60 26 53 23
PDD5
 Mb 5.04 4.06 5.86 14.49 5.30(1, 157) .033e 2.79(1,157) .017c 0.31 (1, 157) .002c
 SDb 13.10 8.97 11.33 22.29 p < .023 p < .097 p > .500
 n 60 26 53 23
JPD
 Mb 4.25 5.85 2.13 6.17 1.23(1, 157) .008c 1.32(1,157) .008c 3.86(1, 157) .024c
 SDb 9.55 23.44 3.80 10.59 p > .200 p > .200 p<.051
 n 60 26 53 23
PDM
 Mb 34.86 31.35 33.80 58.33 4.18(1, 157) .026c 2.28(1,157) .014c 4.37 (1, 157) .027c
 SDb 40.23 38.23 39.63 45.25 p < .042 p > .100 p < .038
 n 60 26 53 23

Notes: η2 is partial η2. MI = motivational interviewing; RT = relaxation training; tx = treatment; dep. = depressive symptoms; DPDD = drinks per drinking day; ADPD = average drinks per day; PHDD = percentage of heavy drinking days; PDD5 = percentage of days drank more than five drinks; JPD = joints per day; PDM = percentage of days used marijuana.

a

F statistic provided with degrees of freedom and associatedp levels;

b

data shown are not log transformed;

c

small effect size (Cohen, 1988);

d

medium effect size;

e

small–medium effect size.

Table 3.

Follow-up tests comparing treatments within depressive symptom levels, and depressive symptoms within treatments

Variable MI vs. RT
Low vs. high depression
Low dep. High dep. MI RT
DPDD
 Fa 3.97 (1, 94), p < .049 0.48(1, 94), p > .400 1.03(1, 94), p > .300 3.50(1, 94), p < .064
 η2 .041b .005c .011c .036d
JPD
 Fa 3.39(1, 151), p < .067 .61 (1, 151), p > .400 0.36(1, 157), p > .500 4.57(1, 157), p < .034
 η2 .021c .004c .002c .028c
PDM
 Fa 6.13(1, 157), p < .014 0.00(1, 157), p > .900 0.18(1, 157), p > .600 6.10(1, 157), p < .015
 η2 .038d .000c .001c .037d

Notes: η2 is partial η2. MI = motivational interviewing; RT = relaxation training; dep. = depressive symptoms; DPDD = drinks per drinking day; JPD = joints per day; PDM = percentage of days used marijuana.

a

F statistic provided with degrees of freedom and associated p levels;

b

medium effect size (Cohen, 1988);

c

small effect size;

d

small—medium effect size.

Results

No significant differences were found between treatment groups on relevant baseline variables including gender, age, ethnicity/race, depressive symptoms, participation in facility or post-release substance treatment, mother's education level, or sentence length. Manualized fidelity procedures indicated that (a) adolescents and research counselors in MI rated elements of RT as less useful than elements of MI, adolescents: t(85) = 24.34, p < .0005; counselors: t(85) = 43.04, p < .0005; (b) adolescents and research counselors in RT rated elements of MI as less useful than elements of RT, adolescents: t(75) = 26.96, p < .0005; counselors: t(75) = 40.06, p < .0005; and (c) adolescents and research counselors rated the therapeutic relationship better (warmth, ease of discussion, instilling hope) in MI than in RT, adolescents: t(160) = 1.96, p < .052; counselors: t(160) = 2.93, p < .004.

Means and standard deviations for covariates at baseline are presented in Table 1. Main effects and the interactions are presented in Table 2. Significant main effects were found for treatment group for average drinks per day, percentage of heavy drinking days, and percentage of days drank more than five drinks. For each of these dependent variables, the MI group had more favorable outcomes.

Table 1.

Means and standard deviations for covariates at baseline

Variable Depressive symptoms
Motivational interviewing
Relaxation therapy
High
Low
High
Low
M SD n M SD n M SD n M SD n
DPDD 10.52 8.31 34 8.94 7.50 16 10.09 6.25 33 12.35 12.68 16
ADPD 2.01 4.60 60 1.66 3.05 26 1.98 3.70 53 1.71 1.90 23
PHDD 13.00 21.26 60 13.31 25.58 26 13.76 23.35 53 13.53 13.53 23
PDD5 12.93 21.27 60 13.05 25.52 26 13.44 23.41 53 12.27 13.57 23
JPD 7.04 10.03 60 5.11 5.87 26 5.86 6.28 53 5.92 5.90 23
PDM 69.32 36.31 60 70.09 36.21 26 67.26 40.36 53 70.15 39.78 23

Notes: Data shown are not log transformed. DPDD = drinks per drinking day; ADPD = average drinks per day; PHDD = percentage of heavy drinking days; PDD5 = percentage of days drank more than five drinks; JPD = joints per day; PDM = percentage of days used marijuana.

No main effects were found for depressive symptoms. The interaction (Treatment Group × Depressive Symptoms) was significant for drinks per drinking day and percentage of days used marijuana. Table 3 presents follow-up tests for significant interactions. At low levels of depressive symptoms, the MI group had significantly fewer drinks per drinking day than the RT group. Effects for RT were marginal when comparing low and high depressive levels, with RT reducing drinks per drinking day more in the high-depressive group.

Depressive Symptoms

At low levels of depressive symptoms, the MI group had a significantly lower percentage of days used marijuana than the RT group. Effects for RT were significant when comparing low and high depressive levels, with RT significantly reducing percentage of days used marijuana more in the high-depressive group. Graphical display is provided in Figure 2.

Figure 2.

Figure 2

Impact of treatment on substance use by depressive symptoms: Drinks per drinking day (top panel) and percentage of days used marijuana (bottom panel). Bars with common letters are significantly different. See Table 3.

Marginal interaction effects were found for joints per day, and follow-up tests are presented in Table 3. At low levels of depressive symptoms, the MI group had marginally fewer joints per day than the RT group. Effects for RT were significant when comparing low and high depressive levels, with RT significantly reducing joints per day more in the high-depressive group than in the low-depressive group.

Discussion

Alcohol- and marijuana-involved adolescents who were recruited from a juvenile correctional facility were successfully assessed, received randomized brief intervention (MI or RT), and were retained at follow-up. Findings clearly demonstrate the acceptability and feasibility of these interventions. Main effects support the use of MI to reduce alcohol use among these adolescents. It is noteworthy that approximately 2.5 hours of MI during incarceration was significantly associated with reduced alcohol use 3 months after release, compared with 2.5 hours of RT. No main effects for depressive symptoms were found. Interaction effects indicate that, compared with RT, MI reduces alcohol and marijuana use in adolescents low in depressive symptoms at the start of incarceration. However, effects do not hold for high levels of depressive symptoms. This may be because adolescents who are low in depressive symptoms are more able to attend to the MI intervention and mobilize resources than are adolescents high in depressive symptoms, an explanation consistent with that of Tapert and colleagues (2003), who suggested that depressive symptoms may be a treatment liability.

In examining interaction effects, neither treatment outperformed the other at high levels of depression. However, it is interesting to note that for adolescents receiving RT, those high in depressive symptoms reduced marijuana use more than those low in depressive symptoms. Had RT been entirely inert, we might expect it to be associated with no effects, although absence of a no-treatment control precludes saying this with certainty. RT was designed to provide relaxation training, which has not been associated with reduction in substance use (Holroyd, 1976; Klanjer et al., 1984), although, on further inspection, this treatment provided elements of meditation and mindfulness (Bishop, 2002; Caspi and Burleson, 2005; Jha et al., 2007; Kabat-Zinn, 1990; Perez-de-Albeniz and Holmes, 2000). In short, meditation focuses awareness on an object, image, sensation, sound, thought, or process (Caspi and Burleson, 2005; Kabat-Zinn, 1990; Perez-de-Albeniz and Holmes, 2000) to bring about mindfulness, or complete attention to the present experience on a moment-to-moment basis (Bishop, 2002; Jha et al., 2007). Evidence is mounting for the effects of such techniques in reducing substance use, psychological distress, recidivism and aggression in prison samples (Bowen et al., 2006, 2007; Hawkins, 2003; Rainforth et al., 2003; Singh et al., 2007).

Although speculative at this time, RT may be more efficacious in reducing marijuana use for adolescents high in depressive symptoms at the start of incarceration for a number of reasons. Adolescents high in depressive symptoms may have difficulty with affect regulation, and marijuana may assist them in regulating affect. Supplying RT may assist these adolescents in modulating affect, thereby reducing use of marijuana for affect regulation. Essentially, the interaction results are consistent with the notion that, in the absence of affect regulation difficulty (i.e., low depression), adolescents may benefit from interventions (i.e., MI) aimed at motivating them to use skill sets to reduce risky behaviors, such as substance use. However, for those adolescents with affect regulation difficulty (i.e., high depression), motivating them to use skills may be moot if they do not first possess the basic tools needed to modulate affect, because it may be the lack of affect regulation that drives risky behaviors such as marijuana use. The relationship between substance use and affect regulation difficulty, and the use of less cognitively based interventions (e.g., meditation) to address this relationship has been documented elsewhere (e.g., see Hoppes, 2006). The current study parallels the work of Witkiewitz and Bowen (2010) who found that, among adults with substance use disorders, those who had higher levels of depression had the best outcomes if they were randomized to mindfulness-based treatment, compared with usual care. More work is needed to examine the potential impact of affect regulation on substance use and treatment outcome.

The clinical significance of study findings is of interest. At 3 months after release, the MI group showed a 65.0% reduction in the percentage of days they drank more than five drinks, whereas the RT group showed a 20.8% reduction. For adolescents low in depressive symptoms early in incarceration, at 3 months after release the MI group showed a 32.1% reduction in drinks per drinking day and a 55.3% reduction in percentage of days used marijuana; the RT group showed reductions of 4.6% and 33.0%, respectively. For adolescents receiving RT, at 3 months after release, those with high depressive symptoms early in incarceration showed a 49.7% reduction in percentage of days used marijuana, whereas the low depression group showed a 16.8% reduction. Clinical implications suggest that front-loading standard facility care with MI has a significant impact on substance use after release, especially for alcohol use. However, MI performs best at reducing marijuana use only for low levels of depressive symptoms as measured early in incarceration.

Findings are encouraging for intervening with substance-using incarcerated adolescents, given the prevalence of alcohol and marijuana use among this population (Lebeau-Craven et al., 2003). Given that in the previous 12 months, 59.9% and 88.9% qualified for alcohol and marijuana use disorders, respectively, these results indicate that brief intervention followed by standard facility psychoeducational treatment is effective for a wide range of alcohol- and marijuana-involved adolescents.

These findings are similar to those of Monti et al. (1999), who found reduced alcohol-related risky behaviors after brief intervention for older adolescents. However, they are also different, in that we found evidence for moderation effects for treatment based on level of depressive symptoms as measured soon after adjudication. Findings are consistent with prior work from this data set indicating that, compared with RT, MI reduces risky sex and risky driving at low levels of depressive symptoms, yet at high levels, results from the two treatments are equivocal (Stein et al., 2006b; Rosengard et al., 2008). It appears that adolescents low in depressive symptoms may be responsive to interventions that increase their motivation to alter alcohol and, especially, marijuana use. This suggests that clinicians working in these settings may wish to consider depressive symptoms during treatment planning. For those adolescents high in depressive symptoms, results are not overwhelming; however, they do suggest that RT may be more suitable for high-depressive adolescents than it is for low-depressive adolescents.

This study is limited by its reliance on self-report methods; however, self-report is one of the most sensitive indicators of substance use. Evidence generally supports accuracy of self-reports (Babor et al., 2002). Adolescents appear to report more misbehaviors than their parents report for them and to self-report more marijuana use than is detected in urinalysis (Dennis et al., 2002). Consistent with this literature, record review contradicted adolescent reports of nonuse in 1.1% of cases for alcohol and in no cases for marijuana. Further, 21.2% and 23.8% of adolescents, respectively, reported alcohol and marijuana use that went undocumented in their records. Similarly, 4.1% of adolescents reporting no marijuana use in the previous month had a positive urine screen, whereas 7.7% that reported use in the past month tested negative. This study used various methods to enhance veridicality of self-reports including privacy during assessments and informing respondents that information would be checked against collateral information (e.g., records, facility staff, and urine screen).

Although the study is limited in its relatively brief follow-up period, it is first important to establish an effect of treatment and then to determine if it can be extended. Future investigations should include longer follow-up periods. This study was also limited in that we did not have a no-treatment control group. However, our design controlled for time spent in the intervention, which allows us to establish that the intervention effect was not a result of attention. We also reasoned that it was ethical to provide some individualized attention to each adolescent enrolled in the study. Because our measure of depressive symptoms measured affect during the past week, high scores may reflect current stressors and/ or long-standing dysphoria. Future studies should consider assessing for lifetime and current major depressive disorder and changes in depression over time that may be related to intervention efforts.

Given that this is one of the first randomized trials conducted in a juvenile correctional facility, it will be important to replicate these findings in other facilities. We selected a broad range of alcohol- and marijuana-involved adolescents, who also had diverse criminal histories. Although the racial and ethnic diversity in the sample enhances generalizability, results may vary depending on population differences in other facilities (for example, mostly aggressive offenders with substance dependence). Similarly, replication with larger sample sizes is very important because the study was relatively underpowered and some subgroup analyses comprised only about 16 participants. Although the percentage of girls recruited is consistent with facility demographics, future studies may wish to oversample girls. Finally, because the sample available for analyses excluded more Whites, findings may be somewhat more applicable to non-White adolescents.

Acknowledgments

The authors gratefully acknowledge Suzanne Sales for conducting analyses, Laurel Murphy for constructing the flow chart, and Shayna Soenksen for creating the graphs.

Footnotes

*

This research was supported by National Institute on Drug Abuse Grant R01 #13375 (to L.A.R. Stein, principal investigator).

References

  1. Abram KM, Teplin LA, McClelland GM, Dulcan MK. Comorbid psychiatric disorders in youth in juvenile detention. Archives of General Psychiatry. 2003;60:1097–1108. doi: 10.1001/archpsyc.60.11.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Babor TF, Webb C, Burleson JA, Kaminer Y. Subtypes for classifying adolescents with marijuana use disorders: Construct validity and clinical implications. Addiction. 2002;97:58–69. doi: 10.1046/j.1360-0443.97.s1.1.x. [DOI] [PubMed] [Google Scholar]
  3. Bardone AM, Krahn DD, Goodman BM, Searles JS. Using interactive voice response technology and timeline follow-back methodology in studying binge eating and drinking behavior: Different answers to different forms of the same question? Addictive Behaviors. 2000;25:1–11. doi: 10.1016/s0306-4603(99)00031-3. [DOI] [PubMed] [Google Scholar]
  4. Barrett H, Slesnick N, Brody JL, Turner CW, Peterson TR. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. Journal of Consulting and Clinical Psychology. 2001;69:802–813. [PubMed] [Google Scholar]
  5. Bein TH, Miller WR, Boroughs JM. Motivational interviewing with alcohol outpatients. Behavioural Psychotherapy. 1993;21:347–356. [Google Scholar]
  6. Bishop SR. What do we really know about mindfulness-based stress reduction? Psychosomatic Medicine. 2002;64:71–83. doi: 10.1097/00006842-200201000-00010. [DOI] [PubMed] [Google Scholar]
  7. Bowen S, Witkiewitz K, Dillworth TM, Marlatt GA. The role of thought suppression in the relationship between mindfulness meditation and alcohol use. Addictive Behaviors. 2007;32:2324–2328. doi: 10.1016/j.addbeh.2007.01.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bowen S, Witkiewitz K, Dillworth TM, Chawla N, Simpson TL, Ostafin BD, Marlatt GA. Mindfulness meditation and substance use in an incarcerated population. Psychology of Addictive Behaviors. 2006;20:343–347. doi: 10.1037/0893-164X.20.3.343. [DOI] [PubMed] [Google Scholar]
  9. Brown JM, Miller WR. Impact of motivational interviewing on participation and outcome in residential alcoholism treatment. Psychology of Addictive Behaviors. 1993;7:211–218. [Google Scholar]
  10. Burke BL, Arkowitz H, Dunn C. The efficacy of motivational interviewing and its adaptations: What we know so far. In: Miller W, Rollnick S, editors. Motivational interviewing: Preparing people for change. 2nd ed. New York, NY: Guilford Press; 2002. pp. 217–250. [Google Scholar]
  11. Caspi O, Burleson KO. Methodological challenges in meditation research. Advances in Mind-Body Medicine. 2005;21:4–11. [PubMed] [Google Scholar]
  12. Charney DA, Paraherakis AM, Negrete JC, Gill KJ. The impact of depression on the outcome of addictions treatment. Journal of Substance Abuse Treatment. 1998;15:123–130. doi: 10.1016/s0740-5472(97)00183-9. [DOI] [PubMed] [Google Scholar]
  13. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. [Google Scholar]
  14. Colby SM, Monti PM, Barnett NP, Rohsenow DJ, Weissman K, Spirito A, Lewander WJ. Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study. Journal of Consulting and Clinical Psychology. 1998;66:574–578. doi: 10.1037//0022-006x.66.3.574. [DOI] [PubMed] [Google Scholar]
  15. Curran GM, Kirchner JE, Worley M, Rookey C, Booth BM. Depressive symptomatology and early attrition from intensive outpatient substance use treatment. The Journal of Behavioral Health Services & Research. 2002;29:138–143. doi: 10.1007/BF02287700. [DOI] [PubMed] [Google Scholar]
  16. Dennis M, Titus JC, Diamond G, Donaldson J, Godley SH, Tims FM, Scott CK the C.Y.T. Steering Committee. The Cannabis Youth Treatment (CYT) experiment: Rationale, study design and analysis plans. Addiction. 2002;97:16–34. doi: 10.1046/j.1360-0443.97.s01.2.x. [DOI] [PubMed] [Google Scholar]
  17. Esposito-Smythers C, Penn JV, Stein LAR, Lacher-Katz M, Spirito A. A test of problem behavior and self-medication theories in incarcerated adolescent males. Journal of Child & Adolescent Substance Abuse. 2008;17:41–56. doi: 10.1080/15470650802292731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. First MB, Gibbon M, Spitzer RL, Williams JBW. User's guide for the Structured Clinical Interview for DSM-IVAxis I Disorders-Research Version. New York, NY: New York State Psychiatric Institute, Biometrics Research Department; 1996. [Google Scholar]
  19. Hawkins MA. Effectiveness of the Transcendental Meditation program in criminal rehabilitation and substance abuse recovery: A review of the research. Journal of Offender Rehabilitation. 2003;36:47–65. [Google Scholar]
  20. Holroyd KA. Cognition and desensitization in the group treatment of test anxiety. Journal of Consulting and Clinical Psychology. 1976;44:991–1001. doi: 10.1037//0022-006x.44.6.991. [DOI] [PubMed] [Google Scholar]
  21. Hoppes K. The application of mindfulness-based cognitive interventions in the treatment of co-occurring addictive and mood disorders. CNS Spectrums. 2006;11:829–851. doi: 10.1017/s1092852900014991. [DOI] [PubMed] [Google Scholar]
  22. Jha AP, Krompinger J, Baime MJ. Mindfulness training modifies subsystems of attention. Cognitive, Affective & Behavioral Neuroscience. 2007;7:109–119. doi: 10.3758/cabn.7.2.109. [DOI] [PubMed] [Google Scholar]
  23. Kabat-Zinn J. Full catastrophe living. New York, NY: Dell; 1990. [Google Scholar]
  24. Karno MP, Longabaugh R. What do we know? Process analysis and the search for a better understanding of Project MATCH's anger-by-treatment matching effect. Journal of Studies on Alcohol. 2004;65:501–512. doi: 10.15288/jsa.2004.65.501. [DOI] [PubMed] [Google Scholar]
  25. Klajner F, Hartman LM, Sobell MB. Treatment of substance abuse by relaxation training: A review of its rationale, efficacy and mechanisms. Addictive Behaviors. 1984;9:41–55. doi: 10.1016/0306-4603(84)90006-6. [DOI] [PubMed] [Google Scholar]
  26. Kranzler HR, del Boca FK, Rounsaville BJ. Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: A posttreatment natural history study. Journal of Studies on Alcohol. 1996;57:619–626. doi: 10.15288/jsa.1996.57.619. [DOI] [PubMed] [Google Scholar]
  27. Lebeau-Craven R, Stein L, Barnett N, Colby SM, Smith JL, Canto AL. Prevalence of alcohol and drug use in an adolescent training facility. Substance Use & Misuse. 2003;38:825–834. doi: 10.1081/ja-120017612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lewis-Esquerre JM, Colby SM, Tevyaw TO, Eaton CA, Kahler CW, Monti PM. Validation of the timeline follow-back in the assessment of adolescent smoking. Drug and Alcohol Dependence. 2005;79:33–43. doi: 10.1016/j.drugalcdep.2004.12.007. [DOI] [PubMed] [Google Scholar]
  29. Marlatt GA, Witkiewitz K. Harm reduction approaches to alcohol use: Health promotion, prevention, and treatment. Addictive Behaviors. 2002;27:867–886. doi: 10.1016/s0306-4603(02)00294-0. [DOI] [PubMed] [Google Scholar]
  30. Masterman PW, Kelly AB. Reaching adolescents who drink harmfully: Fitting intervention to developmental reality. Journal of Substance Abuse Treatment. 2003;24:347–355. doi: 10.1016/s0740-5472(03)00047-3. [DOI] [PubMed] [Google Scholar]
  31. Midanik LT, Hines AM, Barrett DC, Paul JP, Crosby GM, Stall RD. Self-reports of alcohol use, drug use and sexual behavior: Expanding the Timeline Follow-Back technique. Journal of Studies on Alcohol. 1998;59:681–689. doi: 10.15288/jsa.1998.59.681. [DOI] [PubMed] [Google Scholar]
  32. Miller WR, Rollnick S. Motivational interviewing: Preparing people for change. 2nd ed. New York, NY: Guilford Press; 2002. [Google Scholar]
  33. Monti PM, Colby SM, Barnett NP, Spirito A, Rohsenow DJ, Myers M, Lewander W. Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department. Journal of Consulting and Clinical Psychology. 1999;67:989–994. doi: 10.1037//0022-006x.67.6.989. [DOI] [PubMed] [Google Scholar]
  34. National Center on Addiction and Substance Abuse at Columbia University. Criminal neglect: Substance abuse, juvenile justice, and the children left behind. New York, NY: Author; 2004. Retrieved from http://www.casacolumbia.org/templates/Publications_Reports.aspx#r21. [Google Scholar]
  35. Tevyaw TO, Monti PM. Motivational enhancement and other brief interventions for adolescent substance abuse: Foundations, applications and evaluations. Addiction. 2004;99:63–75. doi: 10.1111/j.1360-0443.2004.00855.x. [DOI] [PubMed] [Google Scholar]
  36. Perez-de-Albeniz A, Holmes J. Meditation: Concepts, effects and uses in therapy. International Journal of Psychotherapy. 2000;5:49–58. [Google Scholar]
  37. Radloff LS. CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1:385–401. [Google Scholar]
  38. Radloff LS. The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults. Journal of Youth and Adolescence. 1991;20:149–166. doi: 10.1007/BF01537606. [DOI] [PubMed] [Google Scholar]
  39. Rainforth MV, Alexander CN, Cavanaugh KL. Effects of the Transcendental Meditation program on recidivism among former inmates of Folsom prison: Survival analysis of 15-year follow-up data. Journal of Offender Rehabilitation. 2003;36:181–203. [Google Scholar]
  40. Rosengard C, Stein LAR, Barnett NP, Monti PM, Golembeske C, Lebeau-Craven R, Miranda R. Randomized clinical trial of motivational enhancement of substance use treatment among incarcerated adolescents: Post-release condom non-use. Journal of HIV/AIDS Prevention in Children & Youth. 2008;8:45–64. doi: 10.1300/J499v08n02_04. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Singh NN, Lancioni GE, Singh Joy SD, Winton ASW, Sabaawi M, Wahler RG, Singh J. Adolescents with conduct disorder can be mindful of their aggressive behavior. Journal of Emotional and Behavioral Disorders. 2007;15:56–63. [Google Scholar]
  42. Sobell LC, Maisto SA, Sobell MB, Cooper AM. Reliability of alcohol abusers' self-reports of drinking behavior. Behaviour Research and Therapy. 1979;17:157–160. doi: 10.1016/0005-7967(79)90025-1. [DOI] [PubMed] [Google Scholar]
  43. Sobell LC, Sobell MB. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In: Allen J, Litten RZ, editors. Measuring alcohol consumption: Psychosocial and biological methods. Totowa, NJ: Humana Press; 1992. pp. 41–72. [Google Scholar]
  44. Stein LAR, Colby SM, Barnett NP, Monti PM, Golembeske C, Lebeau-Craven R, Miranda R. Enhancing substance abuse treatment engagement in incarcerated adolescents. Psychological Services. 2006a;3:25–34. doi: 10.1037/1541-1559.3.1.0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stein LAR, Colby SM, Barnett NP, Monti PM, Golembeske C, Lebeau-Craven R. Effects of motivational interviewing for incarcerated adolescents on driving under the influence after release. American Journal on Addictions. 2006b;15:s50–s57. doi: 10.1080/10550490601003680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Stein LAR, Slavet J, Gingras M, Golembeske C. Brief screening in juvenile detention using the Massachusetts Youth Screening Inventory-2. Providence, RI: Brown University; 2004. [Unpublished internal report] [Google Scholar]
  47. Subramaniam GA, Stitzer MA, Clemmey P, Kolodner K, Fishman MJ. Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:1062–1069. doi: 10.1097/chi.0b013e31806c7ad0. [DOI] [PubMed] [Google Scholar]
  48. Tapert SF, Colby SM, Barnett NP, Spirito A, Rohsenow DJ, Myers MG, Monti PM. Depressed mood, gender, and problem drinking in youth. Journal of Child & Adolescent Substance Abuse. 2003;12:55–68. [Google Scholar]
  49. Teplin LA, Abram KM, McClelland GM, Dulcan MK, Mericle AA. Psychiatric disorders in youth in juvenile detention. Archives of General Psychiatry. 2002;59:1133–1143. doi: 10.1001/archpsyc.59.12.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Turner AP, Larimer ME, Sarason IG, Trupin EW. Identifying a negative mood subtype in incarcerated adolescents: Relationship to substance use. Addictive Behaviors. 2005;30:1442–1448. doi: 10.1016/j.addbeh.2005.01.009. [DOI] [PubMed] [Google Scholar]
  51. Witkiewitz K, Bowen S. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. Journal of Consulting and Clinical Psychology. 2010;78:362–374. doi: 10.1037/a0019172. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Studies on Alcohol and Drugs are provided here courtesy of Rutgers University. Center of Alcohol Studies

RESOURCES